AVXL
$3.68
Revenue | $0Mn |
Net Profits | $-8.62Mn |
Net Profit Margins | -Inf% |
Anavex Life Sciences Corp.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Anavex Life Sciences Corp. has generated NaN% jump in its revenue since last 3-months.
Anavex Life Sciences Corp.’s net profit jumped 33.53% since last year same period to $-8.62Mn in the Q4 2023. On a quarterly growth basis, Anavex Life Sciences Corp. has generated 15.02% jump in its net profits since last 3-months.
Anavex Life Sciences Corp.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Anavex Life Sciences Corp. has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Current Year | -0.11 |
Anavex Life Sciences Corp.’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 21.43% jump from last quarter’s estimates.
Anavex Life Sciences Corp.’s earning per share (EPS) estimates for the current year stand at -0.11.
Earning Per Share (EPS) | -0.11 |
Anavex Life Sciences Corp.’s earning per share (EPS) jumped 35.29% since last year same period to -0.11 in the Q4 2023. This indicates that the Anavex Life Sciences Corp. has generated 35.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-27 | -0.15 | -0.12 | 20% |
2023-08-08 | -0.17 | -0.14 | 17.65% |
2024-02-07 | -0.14 | -0.11 | 21.43% |
2023-05-09 | -0.19 | -0.17 | 10.53% |